Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209631) titled 'Serum Lipoprotein-a as a Marker of Severity of Coronary Artery Disease in Aortic Valve Sclerosis Patients' on Sept. 29.

Study Type: Observational

Primary Sponsor: Sohag University

Condition: Serum Lipoprotein(A) Severity Coronary Artery Disease Aortic Valve Sclerosis

Intervention: Other: Serum Lipoprotein-a level

Recruitment Status: Not recruiting

Date of First Enrollment: October 1, 2024

Target Sample Size: 100

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07209631

Published by HT Digital Content Services with permission from Health Daily Digest....